Handling "Not Reportable" Data [Bioanalytics]

posted by AngusMcLean – USA, 2014-11-28 20:09 (4230 d 23:42 ago) – Posting: # 13954
Views: 15,730

it seems to me that the value > 400 WAS discordant with respect to the pharmacoknetic trend of the values prior to it. As such it can be repeated as a pharmacokinetic outlier according to an appropriate SOP. If the two new values for the duplicate repeats carried out are within 20% of each other then according to appropriate SOP then they would be averaged and report this value. The >400 values is rejected as a pharmcokinetic outlier. You need an SOP policy in place to follow and in the analytical report all repeats are Tabulated together with the reason for repeats and final values. This report will reference the Lab. SOPs for repeats

Angus

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
174 visitors (0 registered, 174 guests [including 25 identified bots]).
Forum time: 20:52 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5